As of Jul 31
| +0.73 / +0.87%|
The 14 analysts offering 12-month price forecasts for DexCom Inc have a median target of 77.50, with a high estimate of 100.00 and a low estimate of 39.00. The median estimate represents a -8.45% decrease from the last price of 84.65.
The current consensus among 16 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.